{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:02:34Z","timestamp":1776402154185,"version":"3.51.2"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"David & Lucile Packard Fellowship for Science and Engineering"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Motivation<\/jats:title>\n                    <jats:p>Predicting synergistic cancer drug combinations through computational methods offers a scalable approach to creating therapies that are more effective and less toxic. However, most algorithms focus solely on synergy without considering toxicity when selecting optimal drug combinations. In the absence of combinatorial toxicity assays, a few models use toxicity penalties to balance high synergy with lower toxicity. Still, these penalties have not been explicitly validated against known drug-drug interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this study, we examine whether synergy scores and toxicity metrics correlate with known adverse drug interactions. While some metrics show trends with toxicity levels, our results reveal significant limitations in using them as penalties. These findings highlight the challenges of incorporating toxicity into synergy prediction frameworks and suggest that advancing the field requires more comprehensive combination toxicity data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Availability and implementation<\/jats:title>\n                    <jats:p>The code written for this project is available at https:\/\/github.com\/amw14\/toxicity-cancer-drug-combination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btag007","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T12:34:25Z","timestamp":1768048465000},"source":"Crossref","is-referenced-by-count":1,"title":["Characterizing clinical toxicity in cancer combination therapies"],"prefix":"10.1093","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8956-8978","authenticated-orcid":false,"given":"Alexandra M","family":"Wong","sequence":"first","affiliation":[{"name":"Center for Computational Molecular Biology, Brown University , Providence, RI 02912,","place":["United States"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7833-5164","authenticated-orcid":false,"given":"Cecile P G","family":"Meier-Scherling","sequence":"additional","affiliation":[{"name":"Center for Computational Molecular Biology, Brown University , Providence, RI 02912,","place":["United States"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-8242","authenticated-orcid":false,"given":"Lorin","family":"Crawford","sequence":"additional","affiliation":[{"name":"Microsoft Research , Cambridge, MA 02142,","place":["United States"]}]}],"member":"286","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"2026020308265869500_btag007-B1","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1038\/s41598-024-52814-w","article-title":"Harnessing machine learning to find synergistic combinations for fda-approved cancer drugs","volume":"14","author":"Abd El-Hafeez","year":"2024","journal-title":"Sci Rep"},{"key":"2026020308265869500_btag007-B2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat Biotechnol"},{"key":"2026020308265869500_btag007-B3","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026020308265869500_btag007-B4","doi-asserted-by":"publisher","first-page":"e19078","DOI":"10.7717\/peerj.19078","article-title":"Prediction of cancer cell line-specific synergistic drug combinations based on multi-omics data","volume":"13","author":"Chen","year":"2025","journal-title":"PeerJ"},{"key":"2026020308265869500_btag007-B5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat Commun"},{"key":"2026020308265869500_btag007-B6","doi-asserted-by":"publisher","first-page":"D609","DOI":"10.1093\/nar\/gkae1010","article-title":"Uniprot: the universal protein knowledgebase in 2025","volume":"53","author":"Consortium","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026020308265869500_btag007-B7","first-page":"613","article-title":"Tests for departure from normality","volume":"60","author":"D\u2019Agostino","year":"1973","journal-title":"Biometrika"},{"key":"2026020308265869500_btag007-B8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/biomet\/58.2.341","article-title":"An omnibus test of normality for moderate and large sample size","volume":"58","author":"D\u2019Agostino","year":"1971","journal-title":"Biometrika"},{"key":"2026020308265869500_btag007-B9","author":"Diadkina","year":"2025"},{"key":"2026020308265869500_btag007-B10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF01386390","article-title":"A note on two problems in connexion with graphs","volume":"1","author":"Dijkstra","year":"1959","journal-title":"Numer Math"},{"key":"2026020308265869500_btag007-B11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/00401706.1964.10490181","article-title":"Multiple comparisons using rank sums","volume":"6","author":"Dunn","year":"1964","journal-title":"Technometrics"},{"key":"2026020308265869500_btag007-B12","volume-title":"Primer of Biostatistics","author":"Glantz","year":"2012"},{"key":"2026020308265869500_btag007-B13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1109\/TCBBIO.2024.3522512","article-title":"Gnnsynergy: a multi-view graph neural network for predicting anti-cancer drug synergy","volume":"22","author":"Hao","year":"2025","journal-title":"IEEE Trans Comput Biol Bioinform"},{"key":"2026020308265869500_btag007-B14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nrd.2016.184","article-title":"Phase II and phase III failures: 2013\u20132015","volume":"15","author":"Harrison","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"2026020308265869500_btag007-B15","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","article-title":"The national cancer institute almanac: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity","volume":"77","author":"Holbeck","year":"2017","journal-title":"Cancer Res"},{"key":"2026020308265869500_btag007-B16","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac588","article-title":"Ccsynergy: An integrative deep-learning framework enabling context-aware prediction of anti-cancer drug synergy","volume":"24","author":"Hosseini","year":"2023","journal-title":"Brief Bioinform"},{"key":"2026020308265869500_btag007-B17","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1001\/jamainternmed.2016.6008","article-title":"Failure of investigational drugs in late-stage clinical development and publication of trial results","volume":"176","author":"Hwang","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2026020308265869500_btag007-B18","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s43018-023-00635-7","article-title":"Additivity predicts the efficacy of most approved combination therapies for advanced cancer","volume":"4","author":"Hwangbo","year":"2023","journal-title":"Nat Cancer"},{"key":"2026020308265869500_btag007-B19","doi-asserted-by":"publisher","first-page":"e1007604","DOI":"10.1371\/journal.pcbi.1007604","article-title":"Syntoxprofiler: an interactive analysis of drug combination synergy, toxicity and efficacy","volume":"16","author":"Ianevski","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"2026020308265869500_btag007-B20","first-page":"547","article-title":"\u00c9tude comparative de la distribution florale dans une portion des alpes et des Jura","volume":"37","author":"Jaccard","year":"1901","journal-title":"Bull de la Soc Vaud Des Sci Nat"},{"key":"2026020308265869500_btag007-B21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1469-8137.1912.tb05611.x","article-title":"The distribution of the flora in the alpine zone","volume":"11","author":"Jaccard","year":"1912","journal-title":"New Phytol"},{"key":"2026020308265869500_btag007-B22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2307\/2333011","article-title":"A distribution-free k-sample test against ordered alternatives","volume":"41","author":"Jonckheere","year":"1954","journal-title":"Biometrika"},{"key":"2026020308265869500_btag007-B23","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1038\/s41467-020-19950-z","article-title":"Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects","volume":"11","author":"Julkunen","year":"2020","journal-title":"Nat Commun"},{"key":"2026020308265869500_btag007-B24","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"Drugbank 6.0: the drugbank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026020308265869500_btag007-B25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","article-title":"Use of ranks in one-criterion variance analysis","volume":"47","author":"Kruskal","year":"1952","journal-title":"J Am Stat Assoc"},{"key":"2026020308265869500_btag007-B26","volume-title":"Rdkit: Open-source Cheminformatics","author":"Landrum","year":"2023"},{"key":"2026020308265869500_btag007-B27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrclinonc.2016.96","article-title":"Combine and conquer: challenges for targeted therapy combinations in early phase trials","volume":"14","author":"Lopez","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"2026020308265869500_btag007-B28","doi-asserted-by":"publisher","first-page":"222ra18","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci Transl Med"},{"key":"2026020308265869500_btag007-B29","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1021\/acs.oprd.9b00140","article-title":"The evolution of high-throughput experimentation in pharmaceutical development and perspectives on the future","volume":"23","author":"Mennen","year":"2019","journal-title":"Org Process Res Dev"},{"key":"2026020308265869500_btag007-B30","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The reactome pathway knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026020308265869500_btag007-B31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1021\/c160017a018","article-title":"The generation of a unique machine description for chemical structures-a technique developed at chemical abstracts service","volume":"5","author":"Morgan","year":"1965","journal-title":"J Chem Doc"},{"key":"2026020308265869500_btag007-B32","author":"Murphy","year":"2021"},{"key":"2026020308265869500_btag007-B33","author":"National Cancer Institute","year":"2022"},{"key":"2026020308265869500_btag007-B34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"O\u2019Neil","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"2026020308265869500_btag007-B35","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.cell.2017.11.009","article-title":"Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy","volume":"171","author":"Palmer","year":"2017","journal-title":"Cell"},{"key":"2026020308265869500_btag007-B36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1098\/rspl.1895.0041","article-title":"Note on regression and inheritance in the case of two parents","volume":"58","author":"Pearson","year":"1895","journal-title":"Proc R Soc Lond Ser I"},{"key":"2026020308265869500_btag007-B37","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"Deepsynergy: predicting anti-cancer drug synergy with deep learning","volume":"34","author":"Preuer","year":"2018","journal-title":"Bioinformatics"},{"key":"2026020308265869500_btag007-B38","doi-asserted-by":"publisher","first-page":"btad438","DOI":"10.1093\/bioinformatics\/btad438","article-title":"Deeptrasynergy: drug combinations using multimodal deep learning with transformers","volume":"39","author":"Rafiei","year":"2023","journal-title":"Bioinformatics"},{"key":"2026020308265869500_btag007-B39","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1021\/acs.jcim.3c01486","article-title":"Cfssynergy: combining feature-based and similarity-based methods for drug synergy prediction","volume":"64","author":"Rafiei","year":"2024","journal-title":"J Chem Inf Model"},{"key":"2026020308265869500_btag007-B40","author":"Ranasinghe","year":"2021"},{"key":"2026020308265869500_btag007-B41","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1200\/JCO.2024.42.16_suppl.6529","article-title":"Treatment discontinuation due to toxicity for patients with acute myeloid leukemia (AML) treated on SWOG S1203","volume":"42","author":"Raychaudhuri","year":"2024","journal-title":"JCO"},{"key":"2026020308265869500_btag007-B42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41523-022-00495-x","article-title":"Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel\/trastuzumab (atempt)","volume":"8","author":"Sella","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"2026020308265869500_btag007-B43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020\u20132070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"2026020308265869500_btag007-B44","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/ije\/dyq191","article-title":"The proof and measurement of association between two things","volume":"39","author":"Spearman","year":"2010","journal-title":"Int J Epidemiol"},{"key":"2026020308265869500_btag007-B45","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"2026020308265869500_btag007-B46","doi-asserted-by":"crossref","first-page":"205rv1","DOI":"10.1126\/scitranslmed.3006667","article-title":"High-throughput methods for combinatorial drug discovery","volume":"5","author":"Sun","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026020308265869500_btag007-B47","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The string database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026020308265869500_btag007-B48","author":"Tanimoto","year":"1957"},{"key":"2026020308265869500_btag007-B49","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.21105\/joss.01169","article-title":"Scikit-posthocs: pairwise multiple comparison tests in python","volume":"4","author":"Terpilowski","year":"2019","journal-title":"JOSS"},{"key":"2026020308265869500_btag007-B50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1385-7258(52)50043-X","article-title":"The asymptotic normality and consistency of kendall\u2019s test against trend, when ties are present in one ranking","volume":"55","author":"Terpstra","year":"1952","journal-title":"Indagationes Mathematicae"},{"key":"2026020308265869500_btag007-B51","volume-title":"The Cancer Genome Atlas Program (TCGA)","author":"The Cancer Genome Atlas Research Network","year":"2006"},{"key":"2026020308265869500_btag007-B52","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/nprot.2014.151","article-title":"Similarity-based modeling in large-scale prediction of drug-drug interactions","volume":"9","author":"Vilar","year":"2014","journal-title":"Nat Protoc"},{"key":"2026020308265869500_btag007-B53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Methods"},{"key":"2026020308265869500_btag007-B54","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/cancers16040709","article-title":"Reasons for treatment discontinuation and their effect on outcomes of immunotherapy in Southwest Finland: a retrospective, real-world cohort study","volume":"16","author":"Virtanen","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026020308265869500_btag007-B55","doi-asserted-by":"crossref","first-page":"bbab587","DOI":"10.1093\/bib\/bbab587","article-title":"Prodeepsyn: predicting anticancer synergistic drug combinations by embedding cell lines with protein\u2013protein interaction network","volume":"23","author":"Wang","year":"2022","journal-title":"Brief Bioinform"},{"key":"2026020308265869500_btag007-B56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/ci00057a005","article-title":"Smiles, a chemical language and information system. 1. introduction to methodology and encoding rules","volume":"28","author":"Weininger","year":"1988","journal-title":"J Chem Inf Comput Sci"},{"key":"2026020308265869500_btag007-B57","first-page":"557","article-title":"Correlation and causation","volume":"20","author":"Wright","year":"1921","journal-title":"J Agric Res"},{"key":"2026020308265869500_btag007-B58","doi-asserted-by":"publisher","first-page":"D1200","DOI":"10.1093\/nar\/gkab880","article-title":"Ddinter: an online drug-drug interaction database towards improving clinical decision-making and patient safety","volume":"50","author":"Xiong","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2026020308265869500_btag007-B59","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12539-025-00695-6","article-title":"Predicting synergistic drug combinations based on fusion of cell and drug molecular structures","volume":"17","author":"Yan","year":"2025","journal-title":"Interdiscip Sci"},{"key":"2026020308265869500_btag007-B60","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/jamia\/ocab162","article-title":"Graphsynergy: a network-inspired deep learning model for anticancer drug combination prediction","volume":"28","author":"Yang","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"2026020308265869500_btag007-B61","doi-asserted-by":"publisher","first-page":"W43","DOI":"10.1093\/nar\/gkz337","article-title":"Drugcomb: an integrative cancer drug combination data portal","volume":"47","author":"Zagidullin","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026020308265869500_btag007-B62","doi-asserted-by":"publisher","first-page":"126566","DOI":"10.1016\/j.eswa.2025.126566","article-title":"Systematic prediction of synergistic drug combinations through network-based deep learning framework","volume":"270","author":"Zhang","year":"2025","journal-title":"Expert Syst Appl"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btag007\/66419821\/btag007.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/42\/2\/btag007\/66419821\/btag007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/42\/2\/btag007\/66419821\/btag007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:27:06Z","timestamp":1770125226000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/doi\/10.1093\/bioinformatics\/btag007\/8426183"}},"subtitle":[],"editor":[{"given":"Zhiyong","family":"Lu","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btag007","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,3]]},"article-number":"btag007"}}